GPR119 regulates genetic markers of fatty acid oxidation in cultured skeletal muscle myotubes

Molecular and Cellular Endocrinology

Volumn 365, Issue 1, 2013, Pages 108-118

  Cornall, L M ^a   Mathai, M L ^a,b   Hryciw, D H ^a,b   Simcocks, A C ^a   O'Brien, P E ^c   Wentworth, J M ^c,d   McAinch, A J ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Fatty acid; GPR119; MRNA; Obesity; Skeletal muscle; Type 2 diabetes mellitus

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADIPONECTIN RECEPTOR 1; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CYCLOPHILIN; FATTY ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 119; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA; MESSENGER RNA; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN SH2; PYRUVATE DEHYDROGENASE KINASE 4; SERINE; THREONINE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; FEMALE; GENETIC MARKER; GLUCOSE OXIDATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID DIET; MALE; MOUSE; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SKELETAL MUSCLE; TISSUE CULTURE;

ACIDS, HETEROCYCLIC; ADULT; ANIMALS; BODY MASS INDEX; CELLS, CULTURED; CLONE CELLS; FATTY ACIDS, NONESTERIFIED; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GLUCOSE; HUMANS; MALE; MICE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; OBESITY, MORBID; OXADIAZOLES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84868459320     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2012.10.003     Document Type: Article

References (54)

1. Abu-Elheiga L., Oh W., Kordari P., Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA 2003, 100:10207-10212.
2. Aguer, C., Mercier, J., Yong Wai Man, C., Metz, L., Bordenave, S., Lambert, K., Jean, E., Lantier, L., Bounoua, L., Brun, J.F., Raynaud De Mauverger, E., Andreelli, F., Foretz, M., Kitzmann, M., 2010. Intramyocellular lipid accumulation is associated with permanent relocation ex vivo and in vitro of fatty acid translocase (FAT)/CD36 in obese patients. Diabetologia 53, 1151-1163.
3. Baron A.D., Brechtel G., Wallace P., Edelman S.V. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. 1988, 255:E769-E774.
4. Bruce C.R., Anderson M.J., Carey A.L., Newman D.G., Bonen A., Kriketos A.D., Cooney G.J., Hawley J.A. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 2003, 88:5444-5451.
5. Cameron-Smith D., Burke L.M., Angus D.J., Tunstall R.J., Cox G.R., Bonen A., Hawley J.A., Hargreaves M. A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle. Am. J. Clin. Nutr. 2003, 77:313-318.
6. Cavuoto P., McAinch A.J., Hatzinikolas G., Janovska A., Game P., Wittert G.A. The expression of receptors for endocannabinoids in human and rodent skeletal muscle. Biochem. Biophys. Res. Commun. 2007, 364:105-110.
7. Chen Z.P., Mcconell G.K., Michell B.J., Snow R.J., Canny B.J., Kemp B.E. AMPK signaling in contracting human skeletal muscle: acetyl-CoA carboxylase and NO synthase phosphorylation. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E1202-E1206.
8. Chu Z.L., Carroll C., Alfonso J., Gutierrez V., He H., Lucman A., Pedraza M., Mondala H., Gao H., Bagnol D., Chen R., Jones R.M., Behan D.P., Leonard J. A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like peptide-1 and glucose-dependent insulinotropic peptide release. Endocrinology 2008, 149:2038-2047.
9. Chu Z.L., Jones R.M., He H., Carroll C., Gutierrez V., Lucman A., Moloney M., Gao H., Mondala H., Bagnol D., Unett D., Liang Y., Demarest K., Semple G., Behan D.P., Leonard J. A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. Endocrinology 2007, 148:2601-2609.
10. Cornall L.M., Mathai M.L., Hryciw D.H., Mcainch A.J. Diet-induced obesity up-regulates the abundance of GPR43 and GPR120 in a tissue specific manner. Cell. Physiol. Biochem. 2011, 28:949-958.
11. Cornall, L.M., Hryciw, D.H., Mathai, M.L., McAinch, A.J., 2012. Generations and uses of human primary myotubes. In: Sundaram, C. (Ed.), Muscle Biopsy. InTech Open-Access Publisher, Croatia, pp. 35-64.
12. Da Costa N., Edgar J., Ooi P.T., Su Y., Meissner J.D., Chang K.C. Calcineurin differentially regulates fast myosin heavy chain genes in oxidative muscle fibre type conversion. Cell Tissue Res. 2007, 329:515-527.
13. Dorn J.M., Schisterman E.F., Winkelstein W., Trevisan M. Body mass index and mortality in a general population sample of men and women. The Buffalo Health Study. Am. J. Epidemiol. 1997, 146:919-931.
14. Furuyama T., Kitayama K., Yamashita H., Mori N. Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem. J. 2003, 375:365-371.
15. Gao J., Tian L., Weng G., Bhagroo N.V., Sorenson R.L., O'brien T.D., Luo J., Guo Z. Stimulating beta cell replication and improving islet graft function by GPR119 agonists. Transpl. Int. 2011, 24:1124-1134.
16. Gastaldi G., Russell A., Golay A., Giacobino J.P., Habicht F., Barthassat V., Muzzin P., Bobbioni-Harsch E. Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 2007, 50:2348-2355.
17. Greco A.V., Mingrone G., Giancaterini A., Manco M., Morroni M., Cinti S., Granzotto M., Vettor R., Camastra S., Ferrannini E. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002, 51:144-151.
18. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270-1274.
19. Hu F.B. Globalization of diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011, 34:1249-1257.
20. Jorgensen S.B., Richter E.A., Wojtaszewski J.F. Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise. J. Physiol. 2006, 574:17-31.
21. Kamei Y., Miura S., Suzuki M., Kai Y., Mizukami J., Taniguchi T., Mochida K., Hata T., Matsuda J., Aburatani H., Nishino I., Ezaki O. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J. Biol. Chem. 2004, 279:41114-41123.
22. Katz L.B., Gambale J.J., Rothenberg P.L., Vanapalli S.R., Vaccaro N., Xi L., Polidori D.C., Vets E., Sarich T.C., Stein P.P. Pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-38431055, a novel GPR119 receptor agonist and potential antidiabetes agent, in healthy male subjects. Clin. Pharmacol. Ther. 2011, 90:685-692.
23. Kelley D.E., Williams K.V., Price J.C., Mckolanis T.M., Goodpaster B.H., Thaete F.L. Plasma fatty acids, adiposity, and variance of skeletal muscle insulin resistance in type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 2001, 86:5412-5419.
24. Kim J.Y., Hickner R.C., Cortright R.L., Dohm G.L., Houmard J.A. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E1039-E1044.
25. Kolobova E., Tuganova A., Boulatnikov I., Popov K.M. Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites. Biochem. J. 2001, 358:69-77.
26. Koves T.R., Li P., An J., Akimoto T., Slentz D., Ilkayeva O., Dohm G.L., Yan Z., Newgard C.B., Muoio D.M. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 2005, 280:33588-33598.
27. Lan H., Vassileva G., Corona A., Liu L., Baker H., Golovko A., Abbondanzo S.J., Hu W., Yang S., Ning Y., Del Vecchio R.A., Poulet F., Laverty M., Gustafson E.L., Hedrick J.A., Kowalski T.J. GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis. J. Endocrinol. 2009, 201:219-230.
28. Lauffer L.M., Iakoubov R., Brubaker P.L. GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. Diabetes 2009, 58:1058-1066.
29. Lee J.S., Pinnamaneni S.K., Eo S.J., Cho I.H., Pyo J.H., Kim C.K., Sinclair A.J., Febbraio M.A., Watt M.J. Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites. J. Appl. Physiol. 2006, 100:1467-1474.
30. Lee W.J., Kim M., Park H.S., Kim H.S., Jeon M.J., Oh K.S., Koh E.H., Won J.C., Kim M.S., Oh G.T., Yoon M., Lee K.U., Park J.Y. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem. Biophys. Res. Commun. 2006, 340:291-295.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
32. Loviscach M., Rehman N., Carter L., Mudaliar S., Mohadeen P., Ciaraldi T.P., Veerkamp J.H., Henry R.R. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia 2000, 43:304-311.
33. Lundstrom K. Latest development in drug discovery on G protein-coupled receptors. Curr. Protein Pept. Sci. 2006, 7:465-470.
34. Mathai M.L., Naik S., Sinclair A.J., Weisinger H.S., Weisinger R.S. Selective reduction in body fat mass and plasma leptin induced by angiotensin-converting enzyme inhibition in rats. Int. J. Obes. (Lond.) 2008, 32:1576-1584.
35. McAinch A.J., Steinberg G.R., Mollica J., O'brien P.E., Dixon J.B., Macaulay S.L., Kemp B.E., Cameron-Smith D. Differential regulation of adiponectin receptor gene expression by adiponectin and leptin in myotubes derived from obese and diabetic individuals. Obesity (Silver Spring) 2006, 14:1898-1904.
36. McAinch A.J., Steinberg G.R., Mollica J., O'brien P.E., Dixon J.B., Kemp B.E., Cameron-Smith D. Leptin stimulation of COXIV is impaired in obese skeletal muscle myotubes. Obes. Res. Clin. Pract. 2007, 1:53-60.
37. Mcainch A.J., Cameron-Smith D. Adiponectin decreases pyruvate dehydrogenase kinase 4 gene expression in obese- and diabetic-derived myotubes. Diabetes Obes. Metab. 2009, 11:721-728.
38. Morris D.L., Cho K.W., Zhou Y., Rui L. SH2B1 enhances insulin sensitivity by both stimulating the insulin receptor and inhibiting tyrosine dephosphorylation of insulin receptor substrate proteins. Diabetes 2009, 58:2039-2047.
39. O'brien K.B., O'shea J.J., Carter-Su C. SH2-B family members differentially regulate JAK family tyrosine kinases. J. Biol. Chem. 2002, 277:8673-8681.
40. Odori, S., Hosoda, K., Tomita, T., Fujikura, J., Kusakabe, T., Kawaguchi, Y., Doi, R., Takaori, K., Ebihara, K., Sakai, Y., Uemoto, S., Nakao, K., 2012. GPR119 expression in normal human tissues and islet cell tumors: evidence for its islet-gastrointestinal distribution, expression in pancreatic beta and alpha cells, and involvement in islet function. Metabolism.
41. Overton H.A., Babbs A.J., Doel S.M., Fyfe M.C., Gardner L.S., Griffin G., Jackson H.C., Procter M.J., Rasamison C.M., Tang-Christensen M., Widdowson P.S., Williams G.M., Reynet C. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab. 2006, 3:167-175.
42. Parker H.E., Habib A.M., Rogers G.J., Gribble F.M., Reimann F. Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 2009, 52:289-298.
43. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., Defronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100:8466-8471.
44. Rodriguez A.M., Sanchez J., Tobaruela A., Priego T., Pico C., Palou A. Time-course effects of increased fatty acid supply on the expression of genes involved in lipid/glucose metabolism in muscle cells. Cell. Physiol. Biochem. 2010, 25:337-346.
45. Rosengren A., Wedel H., Wilhelmsen L. Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur. Heart J. 1999, 20:269-277.
46. Seidell J.C. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br. J. Nutr. 2000, 83(Suppl. 1):S5-S8.
47. Soga T., Ohishi T., Matsui T., Saito T., Matsumoto M., Takasaki J., Matsumoto S., Kamohara M., Hiyama H., Yoshida S., Momose K., Ueda Y., Matsushime H., Kobori M., Furuichi K. Lysophosphatidylcholine enhances glucose-dependent insulin secretion via an orphan G-protein-coupled receptor. Biochem. Biophys. Res. Commun. 2005, 326:744-751.
48. Sriwijitkamol A., Coletta D.K., Wajcberg E., Balbontin G.B., Reyna S.M., Barrientes J., Eagan P.A., Jenkinson C.P., Cersosimo E., Defronzo R.A., Sakamoto K., Musi N. Effect of acute exercise on AMPK signaling in skeletal muscle of subjects with type 2 diabetes: a time-course and dose-response study. Diabetes 2007, 56:836-848.
49. Steinberg G.R., Smith A.C., Van Denderen B.J., Chen Z., Murthy S., Campbell D.J., Heigenhauser G.J., Dyck D.J., Kemp B.E. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females. J. Clin. Endocrinol. Metab. 2004, 89:4575-4580.
50. Wellendorph P., Johansen L.D., Brauner-Osborne H. Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol. Pharmacol. 2009, 76:453-465.
51. Wu P., Inskeep K., Bowker-Kinley M.M., Popov K.M., Harris R.A. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 1999, 48:1593-1599.
52. Zhang J., Phillips D.I., Wang C., Byrne C.D. Human skeletal muscle PPARalpha expression correlates with fat metabolism gene expression but not BMI or insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 2004, 286:E168-E175.
53. Zhang J., Wu W., Li D., Guo Y., Ding H. Overactivation of NF-kappaB impairs insulin sensitivity and mediates palmitate-induced insulin resistance in C2C12 skeletal muscle cells. Endocrine 2010, 37:157-166.
54. Zurlo F., Larson K., Bogardus C., Ravussin E. Skeletal muscle metabolism is a major determinant of resting energy expenditure. J. Clin. Invest. 1990, 86:1423-1427.